Laser-assisted in situ keratomileusis for patients with dry eye

Ikuko Toda, Naoko Asano-Kato, Yoshiko Hori-Komai, Kazuo Tsubota

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Objective: To evaluate the efficacy and safety of laser-assisted in situ keratomileusis (LASIK) in patients with preoperative dry eye. Methods: We divided the 543 eyes that underwent LASIK into the following 3 groups: eyes with definite dry eye (DE group), with probable dry eye (PDE group), and without dry eye (NDE group). We evaluated visual outcome, dry-eye status, and complications. Outcome Measures: We compared uncorrected and best-corrected visual acuity, manifest refraction, symptoms, tear function, ocular surface abnormality, complications, corneal sensitivity, endothelial cell count, and patient satisfaction among the groups. Results: We found no significant differences among the groups in uncorrected and best-corrected visual acuity, manifest refraction, and patient satisfaction. A dry-eye symptom, dryness, was more severe in the DE than the NDE group after LASIK. The mean results of the Schirmer test with anesthesia and tear breakup times were significantly lower and the fluorescein score was higher in the DE than the NDE groups after LASIK. We found no differences in the incidence of complications among the groups. Corneal sensitivity was recovered within 6 months after LASIK in the DE and PDE groups and within 3 months in the NDE group. Conclusions: The efficacy and safety of LASIK were not affected by preexisting dry eye. However, preexisting dry eye is a risk factor for severe postoperative dry eye with lower tear function, more vital staining of the ocular surface, and more severe symptoms.

Original languageEnglish
Pages (from-to)1024-1028
Number of pages5
JournalArchives of Ophthalmology
Volume120
Issue number8
Publication statusPublished - 2002
Externally publishedYes

Fingerprint

Laser In Situ Keratomileusis
Tears
Patient Satisfaction
Visual Acuity
Eye Abnormalities
Safety
Fluorescein
Anesthesia
Endothelial Cells
Cell Count

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Toda, I., Asano-Kato, N., Hori-Komai, Y., & Tsubota, K. (2002). Laser-assisted in situ keratomileusis for patients with dry eye. Archives of Ophthalmology, 120(8), 1024-1028.

Laser-assisted in situ keratomileusis for patients with dry eye. / Toda, Ikuko; Asano-Kato, Naoko; Hori-Komai, Yoshiko; Tsubota, Kazuo.

In: Archives of Ophthalmology, Vol. 120, No. 8, 2002, p. 1024-1028.

Research output: Contribution to journalArticle

Toda, I, Asano-Kato, N, Hori-Komai, Y & Tsubota, K 2002, 'Laser-assisted in situ keratomileusis for patients with dry eye', Archives of Ophthalmology, vol. 120, no. 8, pp. 1024-1028.
Toda, Ikuko ; Asano-Kato, Naoko ; Hori-Komai, Yoshiko ; Tsubota, Kazuo. / Laser-assisted in situ keratomileusis for patients with dry eye. In: Archives of Ophthalmology. 2002 ; Vol. 120, No. 8. pp. 1024-1028.
@article{26a1437eb7734ff89b77c5d37cc6f280,
title = "Laser-assisted in situ keratomileusis for patients with dry eye",
abstract = "Objective: To evaluate the efficacy and safety of laser-assisted in situ keratomileusis (LASIK) in patients with preoperative dry eye. Methods: We divided the 543 eyes that underwent LASIK into the following 3 groups: eyes with definite dry eye (DE group), with probable dry eye (PDE group), and without dry eye (NDE group). We evaluated visual outcome, dry-eye status, and complications. Outcome Measures: We compared uncorrected and best-corrected visual acuity, manifest refraction, symptoms, tear function, ocular surface abnormality, complications, corneal sensitivity, endothelial cell count, and patient satisfaction among the groups. Results: We found no significant differences among the groups in uncorrected and best-corrected visual acuity, manifest refraction, and patient satisfaction. A dry-eye symptom, dryness, was more severe in the DE than the NDE group after LASIK. The mean results of the Schirmer test with anesthesia and tear breakup times were significantly lower and the fluorescein score was higher in the DE than the NDE groups after LASIK. We found no differences in the incidence of complications among the groups. Corneal sensitivity was recovered within 6 months after LASIK in the DE and PDE groups and within 3 months in the NDE group. Conclusions: The efficacy and safety of LASIK were not affected by preexisting dry eye. However, preexisting dry eye is a risk factor for severe postoperative dry eye with lower tear function, more vital staining of the ocular surface, and more severe symptoms.",
author = "Ikuko Toda and Naoko Asano-Kato and Yoshiko Hori-Komai and Kazuo Tsubota",
year = "2002",
language = "English",
volume = "120",
pages = "1024--1028",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "8",

}

TY - JOUR

T1 - Laser-assisted in situ keratomileusis for patients with dry eye

AU - Toda, Ikuko

AU - Asano-Kato, Naoko

AU - Hori-Komai, Yoshiko

AU - Tsubota, Kazuo

PY - 2002

Y1 - 2002

N2 - Objective: To evaluate the efficacy and safety of laser-assisted in situ keratomileusis (LASIK) in patients with preoperative dry eye. Methods: We divided the 543 eyes that underwent LASIK into the following 3 groups: eyes with definite dry eye (DE group), with probable dry eye (PDE group), and without dry eye (NDE group). We evaluated visual outcome, dry-eye status, and complications. Outcome Measures: We compared uncorrected and best-corrected visual acuity, manifest refraction, symptoms, tear function, ocular surface abnormality, complications, corneal sensitivity, endothelial cell count, and patient satisfaction among the groups. Results: We found no significant differences among the groups in uncorrected and best-corrected visual acuity, manifest refraction, and patient satisfaction. A dry-eye symptom, dryness, was more severe in the DE than the NDE group after LASIK. The mean results of the Schirmer test with anesthesia and tear breakup times were significantly lower and the fluorescein score was higher in the DE than the NDE groups after LASIK. We found no differences in the incidence of complications among the groups. Corneal sensitivity was recovered within 6 months after LASIK in the DE and PDE groups and within 3 months in the NDE group. Conclusions: The efficacy and safety of LASIK were not affected by preexisting dry eye. However, preexisting dry eye is a risk factor for severe postoperative dry eye with lower tear function, more vital staining of the ocular surface, and more severe symptoms.

AB - Objective: To evaluate the efficacy and safety of laser-assisted in situ keratomileusis (LASIK) in patients with preoperative dry eye. Methods: We divided the 543 eyes that underwent LASIK into the following 3 groups: eyes with definite dry eye (DE group), with probable dry eye (PDE group), and without dry eye (NDE group). We evaluated visual outcome, dry-eye status, and complications. Outcome Measures: We compared uncorrected and best-corrected visual acuity, manifest refraction, symptoms, tear function, ocular surface abnormality, complications, corneal sensitivity, endothelial cell count, and patient satisfaction among the groups. Results: We found no significant differences among the groups in uncorrected and best-corrected visual acuity, manifest refraction, and patient satisfaction. A dry-eye symptom, dryness, was more severe in the DE than the NDE group after LASIK. The mean results of the Schirmer test with anesthesia and tear breakup times were significantly lower and the fluorescein score was higher in the DE than the NDE groups after LASIK. We found no differences in the incidence of complications among the groups. Corneal sensitivity was recovered within 6 months after LASIK in the DE and PDE groups and within 3 months in the NDE group. Conclusions: The efficacy and safety of LASIK were not affected by preexisting dry eye. However, preexisting dry eye is a risk factor for severe postoperative dry eye with lower tear function, more vital staining of the ocular surface, and more severe symptoms.

UR - http://www.scopus.com/inward/record.url?scp=0036338181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036338181&partnerID=8YFLogxK

M3 - Article

VL - 120

SP - 1024

EP - 1028

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 8

ER -